跳至主要内容
临床试验/CTRI/2022/09/045550
CTRI/2022/09/045550招募中未知

Minimum Effective Dose of Carbetocin to Prevent Uterine Atony during Cesarean delivery in preeclampsia versus normotensive patients: A Biased Sequential Allocation Study - NI

CMS and GTB Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Non laboring parturients, with singleton pregnancy, and scheduled for cesarean delivery under spinal anesthesia. Will be allocated to either preeclampsia group or normotensive (control) group, depending on presence or absence of the preeclampsia respectively

排除标准

  • ASA grade III or more, presence of active labor (defined as cervical dilatation of 4 cm or more), preoperative use of oxytocin, other conditions predisposing to postpartum haemorrhage.

研究者

发起方
CMS and GTB Hospital

相似试验